C
Codiak BioSciences Inc is developing exosome-based therapeutics using its engEx Platform to create engineered exosomes for the treatment of diseases with high unmet medical needs, including oncology and neuromuscular disorders. The company aims to provide targeted delivery of therapeutic agents, improving treatment efficacy and patient outcomes in complex disease areas.
Cambridge, United Kingdom
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Codiak BioSciences Inc is developing exosome-based therapeutics using its engEx Platform to create engineered exosomes for the treatment of diseases with high unmet medical needs, including oncology and neuromuscular disorders. The company aims to provide targeted delivery of therapeutic agents, improving treatment efficacy and patient outcomes in complex disease areas.